SCHEMBL20495244

SCHEMBL20495244

CCOC(=O)c1cnn(C2CC(C(F)(F)F)C2)c1N1CCOCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 3/20 0.48
▸ TP53 P04637 2/20 0.48
▸ USP2 O75604 1/20 0.48
▸ RECQL P46063 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.43
▸ MAPT P10636 6/20 0.43
▸ GAA P10253 5/20 0.43
▸ L3MBTL1 Q9Y468 5/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ TDP1 Q9NUW8 3/20 0.43
▸ POLB P06746 3/20 0.42
▸ PDE4B Q07343 3/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ PKM P14618 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ MC4R P32245 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20495068 0.78 ALOX15 (0.44) MAPK1TP53USP2RECQLHSD17B10
SCHEMBL18394918 0.72 MAPK1 (0.51) MAPK1TP53USP2RECQLHSD17B10
SCHEMBL20098255 0.69 ALOX15 (0.60) MAPK1TP53USP2RECQLHSD17B10
SCHEMBL30984353 0.69 PDE4B (0.49) HSD17B10KDM4EPDE4BALDH1A1LMNA
SCHEMBL23289754 0.68 PDE4B (0.48) PDE4BLMNA
SCHEMBL1406858 0.68 PDE4B (0.48) HSD17B10KDM4EMAPTGAASMN1; SMN2
SCHEMBL1406723 0.68 LMNA (0.54) TP53KDM4ESMN1; SMN2PDE4BALDH1A1
SCHEMBL18394950 0.68 ALDH1A1 (0.45) MAPK1KDM4EMAPTTDP1ALDH1A1
SCHEMBL20494864 0.67 KDM4E (0.41) MAPK1TP53USP2RECQLHSD17B10
SCHEMBL1406984 0.67 TRPC1 (0.49) HSD17B10KDM4EMAPTGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570153-B2 Benzodiazepine derivatives as RSV inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2020-02-25 — — US disclosed
US-20180258102-A1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2018-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570153-B2 Benzodiazepine derivatives as RSV inhibitors GABRA5, GABRA1, GABBR2 MAPK1 2860/4885TP53 4857/4885USP2 4534/4885
US-20180258102-A1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS GABRA5, GABRA1, GABBR2 MAPK1 2860/4885TP53 4857/4885USP2 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback